Tessa Therapeutics’ $80 Million Financing Round

Wilson Sonsini Goodrich & Rosati represented Temasek on U.S. matters in the transaction Tessa Therapeutics, an international biopharmaceutical company focused on T-cell therapy for solid tumors,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here